🍄 Could a Mushroom Compound Help Repair Brain Damage After Concussions? What if the brain damage caused by repeated concussions could one day be treated not just by managing symptoms, but by helping the brain repair itself? Scientists have just uncovered a surprising clue — and it comes from an unlikely source: psilocybin, the psychedelic compound found in so-called magic mushrooms. In a new study published in Communications Biology, researchers investigated what happened when psilocybin was given to rats that had experienced repeated mild head injuries. The results were striking. The treatment reduced swelling in the brain, helped restore normal blood-vessel responses, and changed patterns of communication between different brain regions. But the most intriguing discovery was hidden deeper inside the brain. Repeated head trauma can trigger biological changes that are associated with long-term neurological problems. One molecule researchers focused on was phosphorylated tau, a form of the tau protein linked to diseases including chronic traumatic encephalopathy (CTE) and Alzheimer’s disease. After psilocybin treatment, the injured rats showed a major reduction in phosphorylated tau buildup — reaching levels similar to the control animals in the study. Researchers also found increased levels of BDNF and its receptor TrkB, molecules involved in the brain’s ability to adapt, maintain connections and support neuroplasticity. That raises a fascinating possibility: perhaps psilocybin is doing more than simply changing how the brain functions temporarily. It may be influencing some of the biological processes that follow repeated head trauma. Could a psychedelic compound eventually become part of a treatment designed to protect the brains of athletes, soldiers, accident survivors and others exposed to repeated concussions? We are not there yet. This was an animal study, not a clinical trial in people. The researchers used an adult rat model of repetitive mild head injury, meaning we still need carefully controlled human studies to determine whether the same effects occur in people, whether the treatment is safe, and whether it can actually prevent or reverse long-term neurological disease. Still, the idea is remarkable: a compound best known for producing psychedelic experiences may also be capable of influencing brain swelling, blood flow, neural connectivity, tau accumulation and the biological machinery involved in neuroplasticity. Sometimes the strangest scientific clues come from the places we least expect. And this one could be worth watching very closely. Source: Brengel, E. K., Axe, B., Maheswari, A. N., et al. (2026). Psilocybin as a treatment for repetitive mild head injury: evidence from neuroradiology and molecular biology.